We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our cookies and for us to access these on your device. Find out more about how we use cookies and how to change your cookie settings.


Features and backgrounds

The Wellcome Trust is one of the world's leading supporters of research in tropical medicine. Over the last ten years it has funded £150 million of research on malaria, and has supported a number of initiatives that aim to tackle the huge burden of malaria in the developing world.

Major Overseas Programmes

Kenya : the KEMRI-Wellcome Trust Research Programme based at Kilifi on the Kenyan coast and in Nairobi.
Malawi : the Malawi-Liverpool-Wellcome Trust Research Programme, based in Blantyre.
South-east Asia : the Wellcome Trust South-east Asia Programme, based in Thailand and Vietnam.

Wellcome Trust Sanger Institute

One of the world's leading centres of genome sequencing and analysis, the Sanger Institute played a key role in the sequencing of the malaria parasite genome.

Roll Back Malaria World Malaria Day 2010
Emergence of artemisinin resistance on Thai-Myanmar border raises spectre of untreatable malaria: Evidence that the most deadly species of malaria parasite, Plasmodium falciparum, is becoming resistant to the frontline treatment for malaria on the border of Thailand and Myanmar is reported in the 'Lancet'. 05/04/2012
Major clinical trial prompts call for change to treatment guidelines for severe malaria: The largest ever clinical trial among patients hospitalised with severe malaria has concluded that the drug artesunate should now be the preferred treatment for the disease in both children and adults worldwide. The study, funded by the Wellcome Trust, is published online in the 'Lancet'. 08/11/2010
Global map of the sickle cell gene confirms the 'malaria hypothesis': On a global scale, the sickle-cell gene is most commonly found in areas with historically high levels of malaria, adding geographical support to the hypothesis that, while potentially deadly, the gene avoids disappearing through natural selection by providing protection against malaria. 03/11/2010
Human malaria 'came from gorillas': Researchers have shown that the most common form of human malaria originated from infected gorillas. 23/09/2010
Most effective malaria drug combination treatment identified: A study identifies the most effective drug combinations recommended for use as first-line treatments for malaria. 09/09/2010
Mapping malaria
Mapping malaria: Integrated maps, combining data from satellites and other sources are providing new insights into malaria interventions. Mun-Keat Looi talks to Abdisalan Noor, a Wellcome Trust Research Training Fellow in Kenya, on his work in the field of geospatial modelling.
Four species of Plasmodium
Four species of Plasmodium: There are over 120 species of the parasite genus Plasmodium, but only four of these infect humans to cause malaria.
Plasmodium falciparum
Plasmodium falciparum: The Plasmodium falciparum parasite causes the most severe form of malaria, and is found in many tropical and subtropical regions of the world.
The malaria genome unveiled
The malaria genome unveiled: Chris Newbold looks at the some of the key findings in the genome of the malaria parasite Plasmodium falciparum, and the implications for future research.
The malaria medicine chest, part 1
The malaria medicine chest, part 1: With the rise of resistance in the malaria parasite, many antimalarial drugs are becoming useless. Nick White examines the current, perilous situation.
Wellcome Trust, Gibbs Building, 215 Euston Road, London NW1 2BE, UK T:+44 (0)20 7611 8888